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ABSTRACT 
Some previously described environmental associations for atopic eczema (AE) may be due to 
reverse causation. We explored the role of reverse causation by comparing individual- and 
school-level results for multiple AE risk factors. 
ISAAC Phase Three surveyed children within schools (the sampling unit) on AE symptoms 
and potential risk factors. We assessed the effect of these risk factors on AE symptoms using 
mixed-effect logistic regression models, first with individual-level exposure data and second 
with school-level exposure prevalence. 
546,348 children from 53 countries were included. At age 6-7 the strongest individual-level 
associations were with current paracetamol use (odds ratio=1.45, 95% confidence interval 
1.37-1.54), which persisted at school-level (1.55, 1.10-2.21), antibiotics (1.41, 1.34-1.48) and 
early life paracetamol use (1.28, 1.21-1.36) with the former persisting at school-level while 
the latter was no longer observed (1.35, 1.00-1.82 and 0.94, 0.69-1.28 respectively). At age 
13-14 the strongest associations at individual-level were with current paracetamol use (1.57, 
1.51-1.63) and open-fire cooking (1.46, 1.33-1.62); both were stronger at school-level (2.57, 
1.84-3.59 and 2.38, 1.52-3.73 respectively). Association with exposure to heavy traffic (1.31, 
1.27-1.36) also persisted at school-level (1.40, 1.07-1.82). 
Most individual- and school level effects were consistent tending to exclude reverse 
causation. 
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INTRODUCTION 
Atopic eczema (AE) prevalence has increased substantially over the last 30 years; up to 20% 
of children in affluent westernized countries have AE during their lives and prevalence in 
low-and-middle income countries is increasing (Odhiambo et al., 2009). AE can have a major 
impact on sufferers and their families (Balkrishnan et al., 2003, Beattie and Lewis-Jones, 
2006). 
While genetic factors clearly play an important role in AE aetiology, the dramatic increase in 
prevalence of AE in low- and middle-income countries is not consistent with a major role of 
genetic factors (since these do not change rapidly over time), and strongly suggests that 
environmental factors are important (Odhiambo et al., 2009, Sandilands et al., 2006).  
Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) has 
contributed significantly to understanding the associations between single environmental 
exposures and asthma, AE and rhinitis (Asher et al., 2010). However, environmental factors 
may confound each other’s effects in allergic diseases; hence assessing the role of many key 
environmental factors together is useful. Findings of cross-sectional studies, including 
ISAAC, may be limited by reverse causation, where the direction of cause-and-effect is 
contrary to a common presumption. This arises when a child being at risk of or having AE 
has led to changes in environmental exposures. For example, parents may remove pets 
following AE onset if they believe pets exacerbate AE symptoms, resulting in a paradoxical 
association between increased pet exposure and decreased AE when measured at a single 
time point (Brunekreef et al., 2012a, Langan et al., 2007), rather than increased pet exposure 
increasing AE risk. Cross-sectional studies may also be limited by confounding by indication 
where the association with the risk factor has an alternative explanation; for example, AE 
may be complicated by skin infections requiring antibiotic treatment, leading to an observed 
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increased association between AE and antibiotic use, rather than antibiotics being on the 
causal pathway for AE. Confounding by indication has been considered as an alternative 
explanation in relation to paracetamol (acetaminophen) use and asthma aetiology (but not 
AE) in previous ISAAC papers, although paracetamol may be taken for symptoms of severe 
skin and other infections associated with AE.(Beasley et al., 2008) 
In this study, we assessed the effects of the all the key environmental variables previously 
each singly associated with AE in ISAAC at an individual-level, aiming to find which 
variables were the most important. The individuals in ISAAC were within schools (the 
sampling unit). Therefore, at the same time, we also incorporated average school-level 
exposure estimates (calculated from the individual-level data) to assess whether associations 
seen for these multiple variables at individual-level could be due to bias from reverse 
causation.  
In standard individual-level exposure models the estimated effect (here an odds ratio [OR]) 
corresponding to the individual-level risk factor can be interpreted as the OR of the exposed 
compared to the unexposed child, after adjustment for school-level prevalence (as a random 
intercept). This means bias due to reverse causation may be a concern where this is plausible, 
but the estimated effects will not be confounded by unmeasured ecological factors (other 
environmental factors affecting the whole population).  
In school-level exposure prevalence models, the estimated OR corresponding to the school-
level prevalence of the risk factor can be interpreted as the effect on an individual of 
attending a hypothetical school where all children are exposed compared to a hypothetical 
school where no children are exposed. School-level analyses can suffer from ecological bias, 
but there is less concern about reverse causation as the actions of a few parents will not 
significantly affect the school-level prevalence of an exposure. Therefore, comparing the 
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results of these models enables exploration of whether single individual-level risk factors, 
which could plausibly be due to reverse causation, persist or diminish when explored at 
school-level. 
The complementary approach of individual- and school-level analyses used in this paper 
enables exploration of mutual confounding by environmental factors and different forms of 
reverse causation, including avoidance bias and confounding by indication.  
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RESULTS 
6-7 year olds 
The 6-7 year old sample contained 221,280 children (from 3,167 schools, 75 centres, 32 
countries). There were 120,799 children (from 2,165 schools, 59 centres, 22 countries) with 
complete data across all analysis variables. See the data flowchart (Figure 1) for further 
details. Individual- and school-level summary statistics are presented in Table 1 for the 
“common sample” and Table S1 (Supplementary Material) for the “maximum sample” (see 
“Statistical analyses” section for definitions). 
Minimally adjusted associations in the common sample were broadly similar to those in the 
maximum sample (Tables 2 and S3). The strongest associations in the fully-adjusted 
individual-level analyses were for current paracetamol use (odds ratio (OR) = 1.45, 95%CI 
1.37-1.54), antibiotic use in the first year of life (1.41, 1.34-1.48), and paracetamol use in the 
first year of life (1.28, 1.21-1.36) (Table 2).  
In fully-adjusted school-level analyses, the associations for current paracetamol use (1.55, 
1.10-2.21) and early life antibiotic use (1.35, 1.00-1.82) were maintained, but the association 
with early life paracetamol use disappeared (0.94, 0.69-1.28) (Table 2). Stronger associations 
were observed at school-level for open fire cooking (1.84, 0.98-3.45 compared to 1.12, 0.95-
1.32 at individual-level), and maternal tobacco use (1.61, 1.14-2.25 compared to 1.06, 0.99-
1.13 at individual-level). A weak association with current heavy traffic exposure observed at 
individual-level was no longer significant at school level. Associations with breastfeeding 
were similar in individual and school-level analyses (1.11, 1.05-1.18 and 1.06, 0.75-1.48) but 
with less precision. A potentially harmful association of low birthweight with AE symptoms 
was seen at school-level (1.78, 1.07-2.95) compared to a small protective association at 
individual-level (0.89, 0.81-0.97) (Table 2). 
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In analyses stratified by country-level affluence (Tables S4-S5, Supplementary Material), 
there was strong evidence at individual-level that being exposed to a cat, dog or farm animals 
in the first year of life, or maternal contact with farm animals while pregnant, was associated 
with AE symptoms in non-affluent countries at individual level (Tables S4 and S5), while 
none of these associations were observed at school-level in either setting. There was also 
evidence that the association of AE symptoms with current paracetamol was strong at 
individual and school-level with stronger estimates in affluent countries (1.64; 1.49-1.79) 
than non-affluent settings (1.35, 1.25-1.45). Weak associations with breastfeeding were only 
observed at individual-level in affluent countries, but were not observed at school-level, with 
no association being seen in non-affluent countries.  
13-14 year olds 
The full 13-14 year old sample contained 362,048 adolescents (from 2,592 schools, 122 
centres, 54 countries). There were 233,159 adolescents (from 2,039 schools, 97 centres, 41 
countries) with complete data across all analysis variables. See the data flowchart (Fig. 2) for 
further details. Individual- and school-level summary statistics are presented in Table 1 for 
the common sample and Table S1 (Supplementary Material) for the maximum sample. 
Minimally adjusted associations in the common sample were broadly similar to those in the 
maximum sample (Tables 2 and S3). The strongest associations in fully-adjusted individual-
level analyses were for current paracetamol use (1.57, 1.51-1.63), cooking on an open fire 
(1.46, 1.33-1.62), and exposure to heavy truck traffic (1.31, 1.27-1.36) (Table 2).  
In fully-adjusted school-level analyses associations for current paracetamol use (2.57, 1.84-
3.59), cooking on an open fire (2.38, 1.52-3.73) and heavy truck traffic (1.40, 1.07-1.82) were 
maintained (Table 2). An association was also observed at school-level for fast food 
consumption (2.11, 1.66-2.70) with a much weaker association at individual-level (1.05, 
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1.02-1.10). At individual-level there was an association with paternal tobacco use (1.15, 1.10-
1.19), with conflicting findings at school-level (0.64, 0.44-0.94). 
In analyses stratified by country-level affluence (Tables S4-S5, Supplementary Material) 
there was evidence at individual-level that current paracetamol use was slightly more strongly 
associated with AE symptoms in affluent (1.75, 1.60-1.92) than non-affluent (1.53, 1.47-
1.60) countries (Table S4), with stronger associations in both settings at school-level (Table 
S5). There was also some evidence that paternal tobacco use was associated with AE 
symptoms in non-affluent countries (1.17, 1.12-1.23) at individual-level, but not at school-
level, and no association was seen in affluent settings (1.05, 0.96-1.14).  
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DISCUSSION 
This study is the first comprehensive analysis of key risk factors for childhood AE, analysed 
together in a multivariable regression analysis, at individual (child) level to find which 
variables were the most important, and community (school) level to find which ones 
remained important. The school was the sampling unit, so analyses using school-level 
prevalence of exposures offer novel insights into the possible extent of bias due selective 
avoidance or confounding by indication. These forms of reverse causation, which are a 
particular issue in cross-sectional analyses, are less of an issue using school-level exposures 
rather than individual-level exposures. When comparing school-level and individual-level 
findings, if confounding by indication was a major issue, associations would be weaker at 
school-level, whereas if selective avoidance was the source of reverse causation, associations 
at the school-level would appear more harmful. Consistent findings between school and 
individual-level analyses suggest that neither of the two forms of reverse causation explain 
the findings. In contrast, school-level analyses are prone to ecologic (population level) 
confounding, which is not an issue when using the individual-level approach. Given that the 
individual- and school-level analyses will potentially be affected in different ways by reverse 
causation and confounding by indication, we consider it is sensible to fit regression models at 
each level (child within school and school within centre) and compare the results to assess 
robustness to different interpretations, rather than considering one approach more appropriate 
than the other. The analyses use the data from ISAAC Phase Three, where many individual-
level single risk factor analyses found associations, but some of these were not corroborated 
in the present analyses.  
6-7 year olds 
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The 6-7 year old results from the present study are summarised and compared with previous 
ISAAC analyses in Table 3, along with an assessment of potential bias and an outline of the 
biological plausibility of the effect.  
The strongest associations for 6-7 year olds in individual-level analyses were for current 
paracetamol use, and antibiotic and paracetamol use in the first year of life. However in 
school-level analyses, only associations with current paracetamol persisted. These school-
level findings provide evidence against reverse causation, including confounding by 
indication, as an explanation, and thus make a causal link more likely. Associations between 
AE and current paracetamol use are consistent with those from individual-level single risk 
factor analyses in previous ISAAC Phase Three publications, which reported dose-response 
relationships between the quantity of paracetamol taken in the previous year and current AE 
symptoms (medium 1.18 (1.08-1.30) and high 1.87 (1.68-2.08) compared to no paracetamol) 
(Beasley et al., 2008). Possible biological mechanisms underlying the observed association 
between paracetamol use and AE may relate to a depletion of glutathione in antigen 
presenting cells resulting in a shift from a Th1 to a predominantly Th2 immune response. 
(Beasley et al., 2008, Beasley et al., 2011, Peterson et al., 1998)  
Associations with early antibiotic use persisted after adjusting for confounders and were also 
observed in school-level analyses, although this association was weaker, suggesting that 
confounding by indication may partly contribute to the association, but does not completely 
explain it. Findings are consistent with those observed in individual-level single risk factor 
analyses (1.42 (1.33-1.51)) in previous ISAAC Phase Three publications (Foliaki et al., 
2009).  In our further analyses, stratifying by affluence, similar associations with early 
antibiotic use were observed in affluent and non-affluent countries. The reasons for this 
association with antibiotics and potential causality are unclear, with proposed theories 
including changes in the gut microbiome.(Tsakok et al., 2013) 
13 
 
Breastfeeding was associated with a slightly increased risk of AE at individual-level with 
similar but weaker results at school-level. The individual-level association was strongest in 
affluent countries but was not significant at school level (Tables S4 and S5). These 
observations reflect previous reports when assessing breastfeeding as an individual-level 
exposure in ISAAC Phase Three data (1.05, 0.97-1.12) (Bjorksten et al., 2011). Our findings 
do not support the reverse causation theory that in affluent countries those children at highest 
risk of developing AE are more likely to be breastfed (Bjorksten et al., 2011, Yang et al., 
2009).   
We observed evidence of a weak protective effect of low birthweight in individual-level 
analyses in contrast to a potentially harmful effect in school-level analyses. Individual-level 
findings are consistent with the previous ISAAC individual-level single risk factor analyses; 
although additionally these analyses showed no association between birthweight and AE 
severity and the importance of the finding from a public health perspective was not clear 
(Mitchell et al., 2014). It is possible that the opposite school-level association may indicate 
residual socio-economic confounding at community level as schools with a high proportion 
of low birthweight children may be in more deprived areas (Dibben et al., 2006). 
We also observed weak evidence in individual-level analyses that current AE was slightly 
more common in children exposed to cats, dogs and farm animals in the first year of life. 
There were similar results at school-level. In stratified analyses all of these associations were 
restricted only to non-affluent settings, where there is likely to be less awareness of these 
associations with AE, making bias or differential recall of exposure less likely explanations. 
Findings for these combined analyses of the ISAAC Phase Three data are consistent with 
those observed in individual-level single risk factor analyses (Brunekreef et al., 2012a, 
Brunekreef et al., 2012b).  
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Current heavy traffic exposure was associated with a weak increased risk of AE symptoms in 
individual-level but not school-level analyses. A possible explanation for the differential 
associations at individual-level and school-level relates to bias; perhaps parents of individuals 
with current AE symptoms are more concerned about heavy traffic exposure and more likely 
to report it compared to those without symptoms. These findings may help interpret the 
similar associations observed in previous individual-level single risk factor analyses 
(Brunekreef et al., 2009).  
13-14 year olds 
The 13-14 year old results from the present study are summarised and compared with 
previous ISAAC analyses in Table 4, along with an assessment of potential bias and an 
outline of the biological plausibility of the effect.  
The strongest association with current AE in adolescents at individual-level was with current 
paracetamol use, with even stronger potentially harmful associations observed at school-
level. The stronger school-level associations suggest that reverse causation is unlikely to 
explain these associations, although ecological confounding, whereby confounding arises due 
to within-area heterogeneity of exposures, is possible. Findings are consistent with previous 
individual-level single risk factors analyses (Beasley et al., 2011).  
Using open fires for cooking was more strongly associated with current AE symptoms at 
school-level compared to individual-level, findings which could be partially attributed to 
avoidance behaviour in parents of children with current AE (Wong et al., 2013). The 
association with AE observed at individual-level at age 13-14 years with no association at age 
6-7 years is consistent with previous single exposure ISAAC studies.(Wong et al., 2013)  
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Strong potentially harmful associations with AE symptoms were seen for current heavy 
traffic exposure at individual-level and school-level. This is in contrast to the younger age-
group; a possible explanation is that persistent AE may be more severe and more likely to 
react to aeroallergens and irritants. Individual-level analyses demonstrated similar 
associations with a dose-response relationship between levels of exposure to traffic and AE 
symptoms.(Brunekreef et al., 2009)  
Though weak associations were observed at individual-level with current maternal and 
paternal tobacco exposure, at school-level the effect was reversed with weak evidence of a 
protective effect for paternal smoking. This finding might support differential reporting of 
tobacco exposure in those with current AE symptoms or ecologic bias at school level 
(Mitchell et al., 2012).  
Strong associations were observed at school-level with fast food consumption, with very 
weak associations being observed at individual-level. Findings are consistent with previous 
individual-level single risk factor analyses and might plausibly be important for the aetiology 
of AE, although ecologic bias and residual confounding are alternative possibilities (Ellwood 
et al., 2001, Ellwood et al., 2013).  
Weak associations were observed between having two or more siblings and current AE 
symptoms at an individual-level with slightly stronger associations at school-level (but with 
weaker precision). Findings are not consistent with those observed at age 6-7 years of age, 
are in contrast to protective associations reported in individual-level single risk factor 
analyses, and may represent a chance association (Strachan et al., 2015).  
Strengths and limitations of the study  
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The ISAAC study had worldwide coverage and a very large sample size, including countries 
from less affluent settings, thus facilitating the study of environmental factors in varied 
settings (Odhiambo et al., 2009). The use of standardised and validated methods of symptoms 
reporting is a particular strength of the ISAAC study (Flohr et al., 2009). Although self-
reported symptoms may be prone to misclassification, they avoid major diagnostic 
differences due to access to care in different countries and settings, where relying on doctor 
diagnosis may be more problematic. Selection bias is an unlikely explanation for the findings 
as response rates of the children were high (85%).  
Assessment of exposures was based on parental or guardian (6-7 year old children) and study 
participant (13-14 year old adolescents) completion of questionnaires about historical 
exposures rather than objective measures, leading to possible misclassification, which for 
different exposures may be non-differential or may be prone to recall biases or reverse 
causation. Schools were the sampling unit, with individual children of the age group 
responding within the school, and this structure of the cross-sectional survey enabled these 
analyses. 
Both individual-level and school-level analyses may be biased by residual confounding by 
factors that were either imperfectly measured or not measured at all; however, as the 
unmeasured confounders are likely to be different at school and individual level, consistency 
of findings at both levels is reassuring against associations being due to residual confounding. 
Conclusions 
We have further enhanced the ISAAC analyses by using school-level as well as individual-
level exposures, thus allowing us to explore whether specific findings may be due to reverse 
causation, including confounding by indication. Despite plausible mechanisms, we did not 
observe findings supportive of selective avoidance in relation to furry pet exposure. The 
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consistent associations between current paracetamol exposure in both age groups and at both 
individual and school-level argues against reverse causation as the sole explanation. The 
consistent associations between current paracetamol exposure in both age groups and at both 
individual and school-level argues against reverse causation as the sole explanation. If 
paracetamol use in early childhood does have a direct biological role in the development of 
atopic eczema and related disorders such as asthma, then reducing paracetamol use in infancy 
could reduce the incidence of such diseases. Indeed, a randomised controlled prevention trial 
in New Zealand called PIPPA Tamariki (ACTRN12618000303246) that seeks to determine 
whether ibuprofen instead of paracetamol for fever/pain in infancy reduces the incidence of 
asthma and eczema, is already underway. 
Some individual-level single risk factor associations previously identified in ISAAC Phase 
Three data were not corroborated in the present analyses, but several were:  current 
paracetamol use at ages 6-7 and 13-14, early life antibiotic exposure and AE at age 6-7, and 
current heavy road traffic and open fire cooking and AE symptoms at 13-14 years. The novel 
approach of using school-level exposure estimates provides insight that some of the 
previously reported associations in ISAAC Phase Three studies may be due to reverse 
causation, but that paracetamol use is unlikely to be explained in this way.  
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MATERIAL AND METHODS 
Study 
A detailed description of the ISAAC Phase Three methods can be found elsewhere (Ellwood 
et al., 2005), and they will be briefly summarized here. ISAAC Phase Three is a multi-centre, 
multi-country, cross-sectional study of two age groups of schoolchildren (6-7 year old 
children and 13-14 year old adolescents) chosen from a random sample of schools in a 
defined geographical area (Asher et al., 1995).  The Phase Three survey included a 
standardised symptom questionnaire, which obtained data on symptoms of asthma, 
rhinoconjunctivitis and AE (Asher et al., 1995). It also included a supplementary 
questionnaire which obtained data on a wide range of possible risk factors for the 
development of allergic disorders (Beasley et al., 2008). Parents or guardians completed the 
questionnaires for 6-7 year olds and 13-14 year olds answered the questionnaires themselves 
(http://isaac.auckland.ac.nz). Centre eligibility is described in the supplementary methods. 
Variables 
The outcome of interest, AE symptoms in the last 12 months, was defined by positive 
responses to the questions “Has your child/have you ever had an itchy rash which was 
coming and going for at least six months?”, “Has your child/have you had this itchy rash at 
any time in the last 12 months?” and “Has this itchy rash at any time affected any of the 
following places: the folds of the elbows, behind the knees, in front of the ankles, under the 
buttocks, or around the neck, ears or eyes?”.  
Analyses in this paper included only the key environmental variables previously each singly 
associated with AE in ISAAC at an individual-level. Full definitions of the environmental 
risk factors are in Table S2 of the Supplementary Material. 
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Additionally, the analysis considered confounding by sex and highest level of maternal 
education (primary, secondary, tertiary, missing/not stated).  
Finally, stratification by affluence of country was achieved using standard approaches (see 
Supplementary methods).  
Statistical analyses 
The two age groups were analysed separately. All analyses were conducted using mixed 
effect logistic regression models. There are four hierarchies of data in the study design: 
individual, school, centre and country. We accounted for this by including random intercepts 
at each of the higher 3 levels. Sex and highest level of maternal education were adjusted for 
as individual-level confounders in all models. The school-level prevalence of each risk factor 
was calculated as the proportion of children with that risk factor out of all children included 
in the analysis within that school. 
Separate models were used to assess the effects of individual-level exposures and aggregated 
school-level prevalence of exposures on the individual-level outcome. Using the approach 
proposed by (Begg and Parides, 2003), these effects were formally compared within a multi-
level framework, by fitting “hybrid fixed effect models”. Results from these models were 
consistent with a simpler approach and are not discussed further.  
Within each of these approaches, a minimally adjusted model was fitted. This was done on 
two samples (i) the “maximum sample” which was the sub-sample that had no data missing 
for AE, the confounders (sex, level of maternal education) and the one exposure of interest 
(ii) the “common sample” which was the sub-sample that had no data missing for AE, 
confounders and all exposures of interest. A fully adjusted model was also fitted to the 
common sample. Fully adjusted models included all risk factors at the individual level for the 
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individual-level models, school-level prevalence of all the risk factors for the school-level 
models. 
The extent of co-linearity in fully adjusted models was examined by comparing the standard 
errors in the fully adjusted model with the standard errors in the minimally adjusted model 
(common sample). Fully adjusted analyses were additionally stratified by ‘affluent’ and ‘non-
affluent’ countries to assess whether avoidance behaviour may have contributed to observed 
associations (since such behaviour is more likely in more affluent countries). Effect 
modification by country-level affluence was tested for each risk factor separately. 
All analyses were conducted using Stata version 14.2 (StataCorp, 2015). Informed consent 
was obtained from parents of all participating children; the ISAAC Phase Three study was 
approved by local institutional review boards in all participating centres.
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Centro De Enfermedades Alergicas Y Asma de Toluca (Toluca), Dr JV Merida-Palacio, 
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de Barcelona (Barcelona), Dr I Carvajal-Urueña, Centro de Salud de La Ería (Asturias), Dr G 
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Table 1: Summary statistics in subjects with data for atopic eczema symptoms, sex, maternal education and all exposures of interest (the “common 
sample”). 
Age group Variable Individual-level (n = 120,799)  School-level  (n = 2,165) 
Prevalence  Median prevalence Prevalence IQR 
6-7 years 
AE in the last 12 months 0.074  0.064 (0.021, 0.120) 
Farm animals (in utero) 0.077  0.066 (0.023, 0.127) 
Low birthweight 0.077  0.056 (0.022, 0.097) 
Paracetamol (1st year) 0.662  0.707 (0.571, 0.843) 
Antibiotics (1st year) 0.557  0.571 (0.472, 0.654) 
Breastfed ever 0.805  0.837 (0.735, 0.918) 
Cat (1st year) 0.109  0.083 (0.036, 0.167) 
Dog (1st year) 0.198  0.197 (0.100, 0.307) 
Farm animals (1st year) 0.094  0.083 (0.037, 0.148) 
2 or more siblings 0.347  0.328 (0.185, 0.484) 
Heavy Truck traffic (current) 0.380  0.378 (0.270, 0.487) 
Fast food (current) 0.396  0.311 (0.165, 0.500) 
Paternal tobacco (current) 0.318  0.348 (0.211, 0.478) 
Maternal tobacco (current) 0.163  0.167 (0.044, 0.328) 
Paracetamol (current) 0.180  0.142 (0.061, 0.250) 
Open fire cooking (current) 0.019  0.000 (0.000, 0.016) 
Age group Variable Individual-level (n = 233,159)  School-level (n = 2,039) 
Prevalence  Median prevalence Prevalence IQR 
13-14 years 
AE in the last 12 months 0.062  0.048 (0.022, 0.091) 
2 or more siblings 0.541  0.593 (0.377, 0.800) 
Heavy Truck traffic (current) 0.396  0.392 (0.301, 0.500) 
Fast food (current) 0.536  0.528 (0.391, 0.680) 
Paternal tobacco (current) 0.384  0.371 (0.238, 0.490) 
Maternal tobacco (current) 0.183  0.185 (0.036, 0.354) 
Paracetamol (current) 0.270  0.298 (0.177, 0.417) 
Open fire cooking (current) 0.052  0.006 (0.000, 0.029) 
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Table 2. Effects of individual- and school-level exposures on atopic eczema symptoms in the last 12 months in subjects with data for atopic eczema 
symptoms, sex, maternal education and all exposures of interest (the “common sample”). Mixed logistic regression models with random intercepts at 
the school, centre and country levels. 
Age group Exposure Individual-level exposure  School-level exposure 
Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
 Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
6-7 years 
(n = 120,799) 
Farm animals (in utero) 1.32 (1.22, 1.43) 1.11 (1.00, 1.23)  1.48 (1.04, 2.12) 1.05 (0.54, 2.04) 
Low birthweight 0.92 (0.84, 1.01) 0.89 (0.81, 0.97)  2.32 (1.43, 3.76) 1.78 (1.07, 2.95) 
Paracetamol (1st year) 1.53 (1.45, 1.61) 1.28 (1.21, 1.36)  1.11 (0.85, 1.46) 0.94 (0.69, 1.28) 
Antibiotics (1st year) 1.56 (1.49, 1.64) 1.41 (1.34, 1.48)  1.32 (1.00, 1.75) 1.35 (1.00, 1.82) 
Breastfed ever 1.09 (1.03, 1.16) 1.11 (1.05, 1.18)  0.97 (0.69, 1.35) 1.06 (0.75, 1.48) 
Cat (1st year) 1.17 (1.10, 1.25) 1.10 (1.03, 1.17)  1.40 (0.99, 1.97) 1.15 (0.78, 1.71) 
Dog (1st year) 1.12 (1.07, 1.18) 1.05 (1.00, 1.11)  1.20 (0.90, 1.61) 0.96 (0.69, 1.32) 
Farm animals (1st year) 1.32 (1.23, 1.42) 1.16 (1.06, 1.27)  1.50 (1.07, 2.10) 1.15 (0.62, 2.15) 
2 or more siblings 0.96 (0.91, 1.01) 0.95 (0.90, 0.99)  1.26 (1.01, 1.56) 1.11 (0.88, 1.40) 
Heavy Truck traffic (current) 1.16 (1.11, 1.22) 1.11 (1.06, 1.16)  0.92 (0.74, 1.14) 0.81 (0.65, 1.02) 
Fast food (current) 1.03 (0.98, 1.08) 0.99 (0.94, 1.04)  0.94 (0.75, 1.18) 0.96 (0.76, 1.22) 
Paternal tobacco (current) 1.08 (1.03, 1.13) 1.04 (0.99, 1.10)  1.18 (0.92, 1.53) 0.83 (0.61, 1.13) 
Maternal tobacco (current) 1.10 (1.04, 1.17) 1.06 (0.99, 1.13)  1.56 (1.18, 2.07) 1.61 (1.14, 2.25) 
Paracetamol (current) 1.60 (1.51, 1.69) 1.45 (1.37, 1.54)  1.63 (1.17, 2.26) 1.55 (1.10, 2.21) 
Open fire cooking (current) 1.15 (0.97, 1.35) 1.12 (0.95, 1.32)  2.30 (1.27, 4.16) 1.84 (0.98, 3.45) 
Age group Exposure Individual-level exposure  School-level exposure 
Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
 Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
13-14 years 
(n = 233,159) 
2 or more siblings 1.10 (1.05, 1.14) 1.08 (1.03, 1.12)  1.34 (1.04, 1.74) 1.26 (0.97, 1.65) 
Heavy Truck traffic (current) 1.36 (1.31, 1.41) 1.31 (1.27, 1.36)  1.66 (1.28, 2.17) 1.40 (1.07, 1.82) 
Fast food (current) 1.10 (1.05, 1.14) 1.05 (1.02, 1.10)  2.08 (1.63, 2.66) 2.11 (1.66, 2.70) 
Paternal tobacco (current) 1.21 (1.16, 1.25) 1.15 (1.10, 1.19)  0.85 (0.61, 1.17) 0.64 (0.44, 0.94) 
Maternal tobacco (current) 1.19 (1.14, 1.25) 1.11 (1.06, 1.16)  0.72 (0.50, 1.04) 0.79 (0.52, 1.19) 
Paracetamol (current) 1.61 (1.55, 1.67) 1.57 (1.51, 1.63)  2.68 (1.91, 3.75) 2.57 (1.84, 3.59) 
Open fire cooking (current) 1.47 (1.33, 1.62) 1.46 (1.33, 1.62)  2.29 (1.47, 3.57) 2.38 (1.52, 3.73) 
AAdjusted for sex and mothers level of education. BAdditionally adjusted for all other variables in the table.
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Table 3. Associations between eczema symptoms in the last 12 months and risk factors for 6-7 year old age group comparing results from different 
analyses  
Exposure 
Current analysis 
School level 
 
Previous ISAAC analysis 
Assessment of 
bias 
Biological 
plausibility of effect Individual 
levela 
School levelb Comparison Individual levelc 
Comparison with 
current analysis 
Farm 
animals (in 
utero) 
1.11 (1.00, 
1.23) 
1.05 (0.54, 
2.04) 
No association at 
school level 
1.17 (1.07,1.29) 
(Brunekreef et al., 
2012b) 
Consistent  No evidence of 
reverse causation 
bias 
Not observed at 
school level 
Low 
birthweight 
0.89 (0.81, 
0.97) 
1.78 (1.07, 
2.95) 
Individual shows 
a protective effect 
but school level is 
harmful  
0.93 (0.85, 1.01) 
(Mitchell et al., 2014) 
Consistent with 
current individual 
level estimate 
There could be 
SES confounding 
at community level 
Unclear 
Paracetamol 
(1st year) 
1.28 (1.21, 
1.36) 
0.94 (0.69, 
1.28) 
The significantly 
harmful effect 
seen at the 
individual level 
doesn’t show at 
the school-level 
 
1.35 (1.26, 1.45) 
(Beasley et al., 2008) 
Consistent with 
current individual 
level estimate 
Possible evidence 
of reverse 
causation 
Unclear 
Antibiotics 
(1st year) 
1.41 (1.34, 
1.48) 
1.35 (1.00, 
1.82) 
Consistent but 
weaker 
1.42 (1.33,1.51) 
(Foliaki et al., 2009) 
Consistent Confounding by 
indication may 
partly contribute to 
the association.  
Confounding by 
indication may 
contribute 
Breastfed 
ever 
1.11 (1.05, 
1.18) 
1.06 (0.75, 
1.48) 
Consistent but 
weaker 
1.05 (0.97,1.12) 
(Bjorksten et al., 2011) 
Consistent No evidence of 
reverse causation 
bias 
Weak association; 
biological basis not 
clear 
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Cat (1st 
year) 
1.10 (1.03, 
1.17) 
1.15 (0.78, 
1.71) 
Consistent 1.09 (1.01,1.17) 
(Brunekreef et al., 
2012a) 
Consistent No evidence of 
reverse causation 
bias 
- 
Dog (1st 
year) 
1.05 (1.00, 
1.11) 
0.96 (0.69, 
1.32) 
Consistent Not available N/A No evidence of 
effect 
- 
Farm 
animals (1st 
year) 
1.16 (1.06, 
1.27) 
1.15 (0.62, 
2.15) 
Consistent 1.16 (1.07,1.27) 
(Brunekreef et al., 
2012b) 
Consistent No evidence of 
reverse causation 
bias 
Proposed mechanism 
related to endotoxin 
exposure, although 
unclear 
2 or more 
siblings 
0.95 (0.90, 
0.99) 
1.11 (0.88, 
1.40) 
The estimates are 
in opposing 
directions but the 
individual CI is 
contained within 
the school level 
CI 
dCategorical 
No siblings 1.00 (ref) 
One sibling 1.09 (1.03, 
1.15) 
2 siblings 1.01 (0.95, 
1.08) 
3+ siblings 1.04 (0.97, 
1.12) 
(Strachan et al., 2015) 
Hard to compare 
due to different 
models 
If there is an effect, 
it appears small. 
There is no dose 
response 
relationship (from 
previous analysis) 
- 
Heavy truck 
traffic 
(current) 
1.11 (1.06, 
1.16) 
0.81 (0.65, 
1.02) 
The estimates are 
in opposing 
directions with a 
harmful effect at 
the individual 
level 
dCategorical 
Never 1.00 (ref)  
Low 1.07 (0.99, 1.15) 
Med 1.18 (1.09, 1.28) 
Heavy 1.36 (1.23, 1.50) 
(Brunekreef et al., 
2009) 
Consistent with the 
individual level 
estimate 
May relate to bias- 
parents of children 
with eczema may 
move if they are 
concerned about 
traffic exposure 
Unlikely causal 
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Fast food 
(current) 
0.99 (0.94, 
1.04) 
0.96 (0.76, 
1.22) 
Consistent dCategorical 
Never/Occasional 1.00 
(ref) 
1-2/wk 1.04 (0.99, 
1.09) 
3+/wk 1.04 (0.95, 1.14) 
(Ellwood et al., 2013) 
Consistent No evidence of 
effect 
- 
Paternal 
tobacco 
(current) 
1.04 (0.99, 
1.10) 
0.83 (0.61, 
1.13) 
The estimates are 
in opposing 
directions but the 
confidence 
intervals overlap 
substantially 
1.09 (1.04, 1.13) 
(Mitchell et al., 2012) 
Consistent with 
individual level 
effect 
Very weak 
association only 
No dose response 
relationship, unlikely 
causal 
Maternal 
tobacco 
(current) 
1.06 (0.99, 
1.13) 
1.61 (1.14, 
2.25) 
The school level 
harmful effect is 
much greater 
1.15 (1.09, 1.21) 
(Mitchell et al., 2012) 
Shows a stronger 
effect than the 
individual level in 
the current analysis 
 No dose response 
relationship, unlikely 
causal 
Paracetamol 
(current) 
1.45 (1.37, 
1.54) 
1.55 (1.10, 
2.21) 
Consistent dCategorical  
Never/Low 1.00 (ref) 
Med 1.18 (1.08,1.30) 
High 1.87 (1.68,2.08) 
(Beasley et al., 2008) 
 
Consistent, the 
high level is the 
equivalent to a 
positive response 
in the current 
analysis 
No evidence of 
reverse causation 
bias 
Depletion of 
glutathione in antigen 
presenting cells 
resulting in a shift 
from a Th1 to mainly 
Th2 immune 
response. (Beasley et 
al., 2008, Peterson et 
al., 1998) 
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Open fire 
cooking 
(current) 
1.12 (0.95, 
1.32) 
1.84 (0.98, 
3.45) 
Stronger harmful 
effect seen at 
school level 
1.10 (0.91-1.33) 
(Wong et al., 2013) 
Consistent with 
individual level 
effect from current 
analysis 
Possible avoidance 
bias as people with 
children with AE 
remove open fires, 
masking the true 
magnitude of effect 
Persistent AE may be 
associated with 
impaired skin barrier 
and more likely to 
react to aeroallergens 
and irritants 
a - fully adjusted for sex, mothers’ education level and all other variables in the table  
b - fully adjusted for sex, mothers’ education level and school level prevalence of all other variables in the table 
c - could be adjusted for a variety of different variables 
d - no direct comparison possible, so closest results are shown 
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Table 4. Associations between eczema symptoms in the last 12 months and risk factors for 13-14 year old age group comparing results from different 
analyses  
Exposure 
Current analysis 
School level 
 
Previous ISAAC analysis 
Assessment of bias 
Biological 
plausibility of effect Individual 
levela 
School levelb Comparison Individual levelc 
Comparison with 
current analysis 
2 or more 
siblings 
1.08 
(1.03,1.12) 
1.26 (0.97, 
1.65) 
The school level 
shows a stronger 
harmful effect 
although the CI 
includes the full 
individual level 
CI 
dCategorical 
No siblings 1.00 (ref) 
One sibling 0.91 (0.85, 
0.98) 
2 siblings 0.96 (0.88, 
1.03) 
3+ siblings 1.05 (0.97, 
1.13) 
(Strachan et al., 2015) 
Consistent, 
although not easy 
to compare 
 May represent a 
chance association. 
No dose-response 
relationship in 
individual studies. 
Heavy truck 
traffic  
 
(current) 
1.31 (1.27, 
1.36) 
1.40 (1.07, 
1.82) 
Consistent dCategorical 
Never 1.00 (ref)  
Low 1.08 (0.97, 1.19) 
Med 1.30 (1.17, 1.4 ) 
Heavy 1.54 (1.37, 1.73) 
(Brunekreef et al., 
2009) 
Consistent No evidence of 
reverse causation 
bias 
Previous studies 
demonstrated dose-
response relationship 
between levels of 
exposure to traffic and 
AE symptoms. No 
clearly established 
biological mechanism. 
Inverse school-level 
association found in 
6-7-year-olds 
contrasts with the 
positive school-level 
association shown 
here for 13-14-year-
olds, suggesting 
caution in drawing 
firm conclusions 
regarding causality. 
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Fast food 
(current) 
1.05 (1.02, 
1.10) 
2.11 (1.66, 
2.70) 
The school level 
shows a stronger 
harmful effect 
dCategorical 
Never/Occasional 1.00 
(ref) 
1-2/wk 1.04 (0.99, 
1.10) 
3+/wk 1.20 (1.11, 1.28) 
(Ellwood et al., 2013) 
Consistent with 
individual level 
effect in current 
analysis 
Possible avoidance 
bias as people with 
adolescents with AE 
avoid fast food, 
masking the true 
magnitude of effect 
Not fully understood; 
theories around 
ingested fatty acids 
and inflammation.  
Paternal 
tobacco 
(current) 
1.15 (1.10, 
1.19) 
0.64 (0.44, 
0.94) 
The estimates 
are in opposing 
directions but 
the confidence 
intervals overlap 
substantially; 
school-level 
estimates look 
protective.  
1.19 (1.14, 1.25) 
(Mitchell et al., 2012) 
Consistent with 
individual level 
effect in current 
analysis 
The finding might 
support differential 
reporting of tobacco 
exposure in those 
with current AE 
symptoms or 
ecologic bias at 
school level 
- 
Maternal 
tobacco 
(current) 
1.11 (1.06, 
1.16) 
0.79 (0.52, 
1.19) 
The estimates 
are in opposing 
directions but 
the confidence 
intervals overlap 
substantially 
1.22 (1.16, 1.28) 
(Mitchell et al., 2012) 
Stronger effect 
than current 
individual level 
analysis 
As for paternal 
tobacco.  
- 
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Paracetamol 
(current) 
1.57 (1.51, 
1.63) 
2.57 (1.84, 
3.59) 
The school level 
harmful effect is 
much greater 
dCategorical  
Never/Low 1.00 (ref) 
Med 1.31 (1.21, 1.42) 
High 1.99 (1.82, 2.16) 
(Beasley et al., 2011) 
Consistent with 
individual level 
current analysis 
(High is the same 
as the positive 
value in current 
analysis) 
Some evidence of 
possible avoidance 
bias masking the 
true magnitude of 
the harmful effect 
Possible biological 
mechanisms 
underlying the 
observed association 
between paracetamol 
use and AE may relate 
to a depletion of 
glutathione in antigen 
presenting cells 
resulting in a shift 
from a Th1 to a 
predominantly Th2 
immune response 
(Beasley et al., 2011, 
Peterson et al., 1998). 
Open fire 
cooking 
(current) 
1.46 (1.33, 
1.62) 
2.38 (1.52, 
3.73) 
Stronger 
harmful effect 
seen at school 
level. 
1.37 (1.13-1.66) 
(Wong et al., 2013) 
Consistent with 
individual level 
effect in current 
analysis 
Possible avoidance 
bias as people with 
asthmatic children 
remove open fires, 
masking the true 
magnitude of effect 
Persistent AE may be 
associated with 
impaired skin barrier 
and more likely to 
react to aeroallergens 
and irritants. 
a - fully adjusted for sex, mothers’ education level and all other variables in the table  
b - fully adjusted for sex, mothers’ education level and school level prevalence of all other variables in the table 
c - could be adjusted for a variety of different variables 
d - no direct comparison possible, so closest results are shown 
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Figure legends 
Fig. 1. Atopic eczema data flowchart, age 6-7 years 
Fig. 2. Atopic eczema data flowchart, age 13-14 years. 
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Supplementary Material 
Supplementary methods 
Centre and school eligibility criteria 
Only centres that met ISAAC methodology standards were included in the analysis. Excluded 
centres were those with fewer than 1,000 participants or response rates below 60% for the 6-7 
year-old age group or below 70% for the 13-14 year-olds. Centres were also excluded if they 
did not return the Centre Report (Ellwood et al., 2005). Schools with fewer than 10 
participants for a given age group were excluded from that analysis. 
 
Environmental risk factors 
Analyses in this paper included only the key environmental variables previously each singly 
associated with AE in ISAAC at an individual-level. For the 6-7 year olds, risk factors were 
paracetamol use in the first year of life and in the past 12 months (Beasley et al., 2008), 
antibiotic use in the first year of life (Foliaki et al., 2009), breast feeding (Bjorksten et al., 
2011), cat and dog in the home in the first year of life (Brunekreef et al., 2012a), regular 
contact with farm animals in the first year of life (Brunekreef et al., 2012b), regular maternal 
contact with farm animals while pregnant (Brunekreef et al., 2012b), heavy truck traffic 
(Brunekreef et al., 2009), fast food consumption (Ellwood et al., 2013), parental smoking 
(Mitchell et al., 2012), cooking on an open fire (Wong et al., 2013), birthweight (Mitchell et 
al., 2014)  and number of siblings (Strachan et al., 2015). For the 13-14 year olds, risk factors 
were heavy truck traffic (Brunekreef et al., 2009), fast food consumption (Ellwood et al., 
2013), parental smoking (Mitchell et al., 2012), paracetamol use in the past 12 months 
(Beasley et al., 2011), open fire cooking (Wong et al., 2013), and number of siblings 
(Strachan et al., 2015). 
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Most of these items had simple “yes/no” answers. The exceptions have been dichotomised: 
paracetamol use in the last 12 months (at least once per month vs. less than once per month), 
heavy truck traffic (frequently or almost the whole day vs. seldom or never), fast food 
consumption (once per week or more vs. less than once per week), low birthweight (less than 
2.5 kg vs. at least 2.5 kg), and number of siblings (2 or more vs. 1 or fewer). Full definitions 
of the environmental risk factors are in Table S2 of the Supplementary Material. 
Derivation of affluence 
Gross National Income (GNI) as of 2002 (obtained from the World Bank website (The World 
Bank, 2016a) where available and filled in by the Central Intelligence Agency (CIA) World 
Factbook (Central Intelligence Agency, 2002)) and a classification of affluent countries (GNI 
over US$9,205) and non-affluent countries (GNI US$9,205 or lower) taken from the 2001 
World Bank definition of high-income countries versus low- to middle-income countries 
(The World Bank, 2016b).  
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Table S1: Summary statistics in subjects with data for atopic eczema symptoms, sex, level of maternal education and the one exposure of interest 
(the “maximum sample”). 
Age group Variable 
Individual-level  School-level 
n Prevalence  n Median prevalence Prevalence IQR 
6-7 years 
Atopic eczema in the last 12 months 204,771 0.074  2,851 0.067 (0.029, 0.116) 
Farm animals (in utero) 181,600 0.100  2,630 0.078 (0.034, 0.156) 
Low birthweight 169,993 0.085  2,549 0.063 (0.032, 0.106) 
Paracetamol (1st year) 182,134 0.652  2,583 0.700 (0.563, 0.826) 
Antibiotics (1st year) 180,799 0.540  2,663 0.559 (0.462, 0.646) 
Breastfed ever 192,559 0.800  2,701 0.846 (0.736, 0.929) 
Cat (1st year) 189,922 0.120  2,701 0.105 (0.048, 0.200) 
Dog (1st year) 174,772 0.206  2,469 0.222 (0.123, 0.328) 
Farm animals (1st year) 181,744 0.116  2,634 0.098 (0.046, 0.178) 
2 or more siblings 203,603 0.381  2,851 0.375 (0.222, 0.544) 
Heavy Truck traffic (current) 184,503 0.386  2,729 0.382 (0.278, 0.491) 
Fast food (current) 181,864 0.411  2,798 0.333 (0.185, 0.511) 
Paternal tobacco (current) 196,353 0.313  2,748 0.333 (0.193, 0.465) 
Maternal tobacco (current) 199,522 0.141  2,781 0.140 (0.030, 0.301) 
Paracetamol (current) 191,900 0.198  2,734 0.167 (0.079, 0.313) 
Open fire cooking (current) 185,718 0.030  2,724 0.000 (0.000, 0.022) 
13-14 years 
Atopic eczema in the last 12 months 341,577 0.068  2,477 0.055 (0.027, 0.102) 
2 or more siblings 334,708 0.552  2,402 0.621 (0.389, 0.810) 
Heavy Truck traffic (current) 309,621 0.396  2,348 0.394 (0.303, 0.510) 
Fast food (current) 313,066 0.552  2,388 0.552 (0.407, 0.695) 
Paternal tobacco (current) 301,502 0.376  2,259 0.367 (0.239, 0.482) 
Maternal tobacco (current) 329,659 0.181  2,433 0.183 (0.040, 0.333) 
Paracetamol (current) 314,005 0.288  2,404 0.310 (0.195, 0.435) 
Open fire cooking (current) 303,363 0.073  2,321 0.011 (0.000, 0.047) 
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Table S2: Risk Factor definitions 
Risk factors for ages 6-7 Question (asked to parent) Positive Response 
Farm animals (in utero) 
Has the child’s mother had regular (at least once a week) contact with farm animals 
(e.g. cattle, pigs, goats, sheep or poultry) while being pregnant with this child? 
Yes  
Low birthweight What was the weight of your child when he / she was born? Less than 2.5kg 
Paracetamol (1st year) 
In the first 12 months of your child’s life, did you usually give paracetamol for 
fever? 
Yes 
Antibiotics (1st year) In the first 12 months of your child’s life, did your child have any antibiotics? Yes 
Breastfed ever Was your child breastfed? Yes 
Cat (1st year) Did you have a cat in your home during the first year of your child’s life? Yes 
Dog (1st year) Did you have a dog in your home during the first year of your child’s life? Yes 
Farm animals (1st year) 
In your child’s first year of life, did he / she have regular (at least once a week) 
contact with farm animals (e.g. cattle, pigs, goats, sheep or poultry)? 
Yes 
2 or more siblings How many older and younger brothers and sisters does your child have? Total of 2 or more 
Heavy truck traffic (current) How often do trucks pass through the street where you live, on weekdays? Frequently or almost the whole day 
Fast food (current) In the past 12 months, how often, on average did your child eat fast food / burgers? At least once a week 
Paternal tobacco (current) Does your child’s father (or male guardian) smoke cigarettes? Yes 
Maternal tobacco (current) Does your child’s mother (or female guardian) smoke cigarettes? Yes 
Paracetamol (current) 
In the past 12 months, how often, on average, have you given your child 
paracetamol? 
At least once a month 
Open fire cooking (current) 
In your house, what fuels are usually used for cooking? Electricity, Gas, Open fires, 
Other  
Any that include open fires 
   
Risk factors for ages 13-14 Question (asked to child) Positive Response 
2 or more siblings How many older and younger brothers and sisters do you have?  Total of 2 or more 
Heavy truck traffic (current) How often do trucks pass through the street where you live, on weekdays? Frequently or almost the whole day 
Fast food (current) In the past 12 months, how often, on average did you eat fast food / burgers? At least once a week 
Paternal tobacco (current) Does your father (or male guardian) smoke cigarettes? Yes 
Maternal tobacco (current) Does your mother (or female guardian) smoke cigarettes? Yes 
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Paracetamol (current) In the past 12 months, how often, on average, have you taken paracetamol? At least once a month 
Open fire cooking (current) 
In your house, what fuels are usually used for cooking? Electricity, Gas, Open fires, 
Other  
Any that include open fires 
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Table S3. Minimally adjustedA effects of individual- and school-level exposures on atopic eczema symptoms in the last 12 months in subjects 
with data for atopic eczema symptoms, sex, level of maternal education and the one exposure of interest (the “maximum sample”). Mixed 
logistic regression models with random intercepts at the school, centre and country levels. 
Age group Exposure 
Individual-level exposure  School-level exposure 
n OR (95% CI)  n OR (95% CI) 
6-7 years 
Farm animals (in utero) 181,600 1.37 (1.29, 1.45)  181,600 1.85 (1.39, 2.45) 
Low birthweight 169,993 0.93 (0.86, 1.00)  169,993 1.65 (1.07, 2.55) 
Paracetamol (1st year) 182,134 1.55 (1.48, 1.62)  182,134 1.12 (0.87, 1.44) 
Antibiotics (1st year) 180,799 1.60 (1.53, 1.66)  180,799 1.29 (1.00, 1.66) 
Breastfed ever 192,559 1.09 (1.04, 1.14)  192,559 0.94 (0.69, 1.26) 
Cat (1st year) 189,922 1.27 (1.21, 1.34)  189,922 1.79 (1.33, 2.41) 
Dog (1st year) 174,772 1.16 (1.11, 1.21)  174,772 1.48 (1.14, 1.92) 
Farm animals (1st year) 181,744 1.41 (1.34, 1.49)  181,744 2.06 (1.56, 2.72) 
2 or more siblings 203,603 0.98 (0.94, 1.01)  203,603 1.44 (1.20, 1.73) 
Heavy Truck traffic (current) 184,503 1.19 (1.14, 1.23)  184,503 1.15 (0.94, 1.39) 
Fast food (current) 181,864 1.03 (0.99, 1.07)  181,864 0.84 (0.69, 1.02) 
Paternal tobacco (current) 196,353 1.11 (1.07, 1.16)  196,353 1.27 (1.01, 1.60) 
Maternal tobacco (current) 199,522 1.17 (1.11, 1.22)  199,522 1.61 (1.24, 2.09) 
Paracetamol (current) 191,900 1.60 (1.53, 1.67)  191,900 1.69 (1.28, 2.23) 
Open fire cooking (current) 185,718 1.14 (1.02, 1.29)  185,718 2.98 (1.83, 4.85) 
Age group Exposure 
Individual-level exposure  School-level exposure 
n OR (95% CI)  n OR (95% CI) 
13-14 years 
2 or more siblings 334,708 1.06 (1.03, 1.10)  334,708 1.25 (0.99, 1.57) 
Heavy Truck traffic (current) 309,621 1.31 (1.27, 1.35)  309,621 1.53 (1.20, 1.96) 
Fast food (current) 313,066 1.09 (1.06, 1.13)  313,066 1.85 (1.48, 2.32) 
Paternal tobacco (current) 301,502 1.22 (1.18, 1.26)  301,502 0.72 (0.54, 0.96) 
Maternal tobacco (current) 329,659 1.23 (1.19, 1.28)  329,659 0.91 (0.66, 1.24) 
Paracetamol (current) 314,005 1.57 (1.52, 1.62)  314,005 2.14 (1.59, 2.88) 
Open fire cooking (current) 303,363 1.43 (1.34, 1.53)  303,363 1.50 (1.09, 2.06) 
AAdjusted for sex and mothers level of education. 
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Table S4. Fully adjustedA effects of individual-level exposures on atopic eczema symptoms in the last 12 months in subjects with data for atopic 
eczema symptoms, sex, maternal education and all exposures of interest (the “common sample”), stratified by country-level affluence. Mixed 
logistic regression models with random intercepts at the school, centre and country levels. 
Age 
group 
Exposure 
Affluent Countries 
(n = 43,374) 
 Non-Affluent countries 
(n = 77,425) 
Effect  
modification 
p-value Number exposed (%) OR (95% CI)  Number exposed (%) OR (95% CI) 
6-7 years 
Farm animals (in utero) 2,970 (6.8) 1.00 (0.84, 1.20)  6,365 (8.2) 1.19 (1.06, 1.35) <0.001 
Low birthweight 2,508 (5.8) 0.92 (0.80, 1.06)  6,763 (8.7) 0.85 (0.76, 0.96) 0.51 
Paracetamol (1st year) 27,222 (62.8) 1.29 (1.17, 1.41)  52,751 (68.1) 1.30 (1.21, 1.40) 0.93 
Antibiotics (1st year) 22,736 (52.4) 1.44 (1.34, 1.55)  44,504 (57.5) 1.37 (1.28, 1.47) 0.33 
Breastfed ever 29,658 (68.4) 1.16 (1.07, 1.25)  67,532 (87.2) 1.05 (0.97, 1.15) 0.11 
Cat (1st year) 6,717 (15.5) 1.01 (0.92, 1.10)  6,508 (8.4) 1.21 (1.09, 1.33) <0.001 
Dog (1st year) 8,102 (18.7) 0.98 (0.90, 1.06)  15,790 (20.4) 1.09 (1.02, 1.17) <0.001 
Farm animals (1st year) 3,688 (8.5) 0.96 (0.81, 1.13)  7,662 (9.9) 1.29 (1.15, 1.44) <0.001 
2 or more siblings 12,887 (29.7) 0.95 (0.89, 1.03)  29,066 (37.5) 0.93 (0.87, 1.00) 0.95 
Heavy Truck traffic 
(current) 
14,353 (33.1) 1.07 (1.00, 1.15)  31,515 (40.7) 1.14 (1.07, 1.21) 0.14 
Fast food (current) 13,496 (31.1) 1.05 (0.97, 1.13)  34,343 (44.4) 0.96 (0.89, 1.02) 0.10 
Paternal tobacco (current) 16,991 (39.2) 1.05 (0.98, 1.14)  21,468 (27.7) 1.04 (0.97, 1.11) 0.40 
Maternal tobacco 
(current) 
12,058 (27.8) 1.00 (0.92, 1.08)  7,620 (9.8) 1.15 (1.05, 1.26) 0.008 
 Paracetamol (current) 5,011 (11.6) 1.64 (1.49, 1.79)  16,724 (21.6) 1.35 (1.25, 1.45) 0.003 
Open fire cooking 
(current) 
255 (0.6) 1.09 (0.73, 1.63)  2,000 (2.6) 1.10 (0.92, 1.33) 0.60 
Age 
group 
Exposure 
Affluent Countries 
(n=48,626) 
 Non-Affluent Countries 
(n=184,533) 
Effect  
modification 
p-value Number exposed (%) OR (95% CI)  Number exposed (%) OR (95% CI) 
13-14 
years 
2 or more siblings 18,086 (37.2) 1.06 (0.97, 1.16)  108,122 (58.6) 1.08 (1.03, 1.13) 0.51 
Heavy Truck traffic 
(current) 
17,725 (36.5) 1.32 (1.21, 1.44)  74,568 (40.4) 1.31 (1.26, 1.37) 0.81 
Fast food (current) 24,780 (51.0) 1.06 (0.97, 1.15)  100,139 (54.3) 1.06 (1.01, 1.10) 0.79 
Paternal tobacco (current) 19,486 (40.1) 1.05 (0.96, 1.14)  70,043 (38.0) 1.17 (1.12, 1.23) 0.01 
Maternal tobacco 
(current) 
14,713 (30.3) 1.09 (0.99, 1.20)  27,899 (15.1) 1.12 (1.06, 1.18) 0.31 
Paracetamol (current) 13,211 (27.2) 1.75 (1.60, 1.92)  49,682 (26.9) 1.53 (1.47, 1.60) 0.007 
Open fire cooking 
(current) 
513 (1.1) 1.55 (1.10, 2.18)  11,565 (6.3) 1.44 (1.30, 1.60) 0.73 
AAdjusted for sex, mother's level of education and all other variables in the table.  
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Table S5: Fully adjustedA effects of school-level exposures on prevalence on atopic eczema symptoms in the last 12 month in subjects with data 
for atopic eczema symptoms, sex, maternal education and all exposures of interest (the “common sample”), stratified by country-level affluence. 
Mixed logistic regression models with random intercepts at the school, centre and country levels. 
Age group Exposure 
Affluent countries 
(n = 43,374) 
 Non-affluent countries 
(n = 77,425) 
Effect  
modification 
p-value Median prevalence OR (95% CI)  Median prevalence OR (95% CI) 
6-7 years 
Farm animals (in utero) 0.06 1.51 (0.56, 4.03)  0.07 0.77 (0.30, 1.97) 0.13 
Low birthweight 0.05 1.16 (0.49, 2.73)  0.06 1.87 (0.94, 3.70) 0.19 
Paracetamol (1st year) 0.76 1.29 (0.82, 2.05)  0.68 0.88 (0.58, 1.34) 0.28 
Antibiotics (1st year) 0.57 1.39 (0.91, 2.12)  0.58 1.23 (0.79, 1.90) 0.41 
Breastfed ever 0.74 1.15 (0.77, 1.71)  0.89 0.83 (0.45, 1.54) 0.35 
Cat (1st year) 0.10 1.02 (0.64, 1.64)  0.08 1.45 (0.68, 3.09) 0.03 
Dog (1st year) 0.19 0.79 (0.51, 1.24)  0.21 1.18 (0.72, 1.92) 0.03 
Farm animals (1st year) 0.08 0.57 (0.22, 1.47)  0.09 1.86 (0.81, 4.31) 0.02 
2 or more siblings 0.28 1.01 (0.72, 1.40)  0.36 1.08 (0.77, 1.51) 0.44 
Heavy Truck traffic (current) 0.33 0.83 (0.60, 1.14)  0.40 0.83 (0.60, 1.16) 0.77 
Fast food (current) 0.27 0.79 (0.54, 1.17)  0.36 1.11 (0.81, 1.52) 0.34 
Paternal tobacco (current) 0.42 1.02 (0.67, 1.55)  0.29 0.61 (0.38, 0.99) 0.57 
Maternal tobacco (current) 0.30 1.43 (0.96, 2.14)  0.08 1.88 (1.01, 3.51) 0.54 
Paracetamol (current) 0.12 2.05 (1.23, 3.42)  0.17 1.35 (0.83, 2.22) 0.38 
Open fire cooking (current) 0.00 2.75 (0.40, 18.79)  0.00 1.62 (0.80, 3.27) 0.97 
Age group Exposure 
Affluent countries 
(n = 48,626) 
 Non-affluent countries 
(n = 184,533) 
Effect  
modification 
p-value Median prevalence OR (95% CI)  Median prevalence OR (95% CI) 
13-14 years 
2 or more siblings 0.35 1.26 (0.76, 2.10)  0.68 1.33 (0.97, 1.82) 0.16 
Heavy Truck traffic (current) 0.37 0.99 (0.53, 1.84)  0.40 1.47 (1.10, 1.97) 0.12 
Fast food (current) 0.50 1.40 (0.80, 2.43)  0.55 2.42 (1.84, 3.20) 0.03 
Paternal tobacco (current) 0.43 0.45 (0.21, 0.95)  0.34 0.73 (0.47, 1.12) 0.16 
Maternal tobacco (current) 0.35 1.46 (0.68, 3.12)  0.13 0.64 (0.39, 1.04) 0.48 
Paracetamol (current) 0.30 2.38 (1.26, 4.51)  0.29 2.62 (1.79, 3.85) 0.58 
Open fire cooking (current) 0.00 1.08 (0.04, 26.81)  0.01 2.26 (1.40, 3.66) 0.45 
AAdjusted for sex, mother's level of education and all other variables in the table. 
